Effect of controlled-release levodopa/carbidopa on the microstructure of sleep in Parkinson's disease (PD)

被引：0
|
作者：
Wailke, S.
Deuschl, G.
Volkmann, J.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [31] Motor function assessment in advanced Parkinson's disease (PD) patients after IPX066 and controlled-release carbidopa-levodopa (CR) using the Unified Parkinson's Disease Rating Scale (UPDRS) and the objective Parkinson's disease measurement (OPDM)
    Tetrud, J.
    Liang, G.
    Ellenbogen, A.
    Duker, A.
    Hsu, A.
    O'Connell, M.
    Khanna, S.
    Kell, S.
    Gupta, S.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S270 - S270
  • [32] Sleep disturbances in drug naive Parkinson's disease (PD) patients and effect of levodopa on sleep
    Ferreira, Teresa
    Prabhakar, Sudesh
    Kharbanda, Parampreet S.
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2014, 17 (04) : 416 - 419
  • [33] EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS
    AHTILA, S
    KAAKKOLA, S
    GORDIN, A
    KORPELA, K
    HEINAVAARA, S
    KARLSSON, M
    WIKBERG, T
    TUOMAINEN, P
    MANNISTO, PT
    [J]. CLINICAL NEUROPHARMACOLOGY, 1995, 18 (01) : 46 - 57
  • [34] Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease
    Hauser, Robert A.
    Ellenbogen, Aaron
    Khanna, Sarita
    Gupta, Suneel
    Modi, Nishit B.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 839 - 845
  • [35] CONTROLLED-RELEASE LEVODOPA
    BLUMENTHAL, HJ
    [J]. NEUROLOGY, 1993, 43 (12) : 2728 - 2729
  • [36] Immediate release and controlled-release carbidopa/levodopa in PD: A 5-year randomized multicenter study - Reply from the author
    Koller, WC
    [J]. NEUROLOGY, 2000, 55 (01) : 157 - 157
  • [37] Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa
    Choudhary, H.
    Agrawal, A. K.
    Malviya, R.
    Yadav, S. K.
    Jaliwala, Y. A.
    Patil, U. K.
    [J]. PHARMAZIE, 2010, 65 (03): : 194 - 198
  • [38] Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease - A multicenter 5-year study
    Block, G
    Liss, C
    Reines, S
    Irr, J
    Nibbelink, D
    Aarli, J
    Aguilar, M
    Ahrens, S
    Bakheit, A
    Baumel, B
    Bertoni, J
    Capildeo, R
    CastroCaldas, A
    Deza, L
    Donaldson, I
    Franck, G
    Fusillo, J
    Gauthier, S
    Gershanik, O
    Granerus, AK
    Hauser, RA
    Hennessey, K
    Hutton, JT
    Joffe, R
    Koller, W
    Last, B
    LeWitt, P
    Mamoli, B
    Manyam, B
    Mark, M
    Nakano, K
    Nausieda, P
    Otero, E
    Paulson, G
    Pinter, M
    Reich, S
    Rodnitzky, R
    Sage, J
    Sampaio, C
    Smith, B
    Teravainen, H
    Tetrud, J
    Tolosa, E
    Ulm, G
    Valesco, F
    [J]. EUROPEAN NEUROLOGY, 1997, 37 (01) : 23 - 27
  • [39] CONTROLLED-RELEASE CARBIDOPA-LEVODOPA (SINEMET) IN COMBINATION WITH STANDARD SINEMET IN ADVANCED PARKINSONS-DISEASE
    MARK, MH
    SAGE, JI
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1989, 19 (02): : 101 - 106
  • [40] LONG-TERM EFFICACY OF CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN PATIENTS WITH ADVANCED PARKINSONS-DISEASE
    MARK, MH
    SAGE, JI
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1989, 19 (06): : 415 - 421
12345